Prevail Therapeutics raises $50M for gene therapy in Parkinson’s, other neurodegenerative disorders – MedCity News

Prevail Therapeutics raises $50M for gene therapy in Parkinson’s, other neurodegenerative disorders – MedCity News
Prevail Therapeutics raises $50M for gene therapy in Parkinson's, other neurodegenerative disorders  MedCity NewsThe company hopes the funding will move it toward the clinic. Active clinical programs of gene therapies in Parkinson's include efforts by Voyager Therapeutics ... read more
Source: Google NewsPublished on 2019-03-27